Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
SLT is a cost-effective, first-line glaucoma approach
Selective laser trabeculoplasty (SLT) could be an affordable option for glaucoma management, according to Nathan Radcliffe, MD.
Nathan Radcliffe, MD, shares why selective laser trabeculoplasty (SLT) is a cost-effective, first-line approach for glaucoma patients at the annual 2019 ASCRS meeting in San Diego. You can read more about the research on this topic here.
RELATED: Moderate-monovision outcomes see improvement with small aperture IOLs
Related Videos
Related Content
